Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin.
Authors not listed
AB Biotics, SA · 2026
Abstract
The purpose of this study is to build insights to understand how the placebo and active impacts the skin microbiome in women with high skin sensitivity (SS10 \> 13) and sun exposure. Microbiome samples will be taken at baseline after 2 weeks of using the placebo (base without active) as a run-in period followed by the usage of placebo for an additional 4 weeks. The participants will then start the usage of active formula for an additional 8 weeks with microbiome samples collected at the 10-week and 14-week. This will allow us to observe how the microbiome changes over time after the product usage of both placebo and active formulations relative to the pre-regimen condition. In addition, headshot photos will be taken using the Haut AI application at each time point concurrent to the microbiome sample collection to examine changes in skin appearances after the regimen.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2026). Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin. <em>AB Biotics, SA</em>. https://clinicaltrials.gov/study/NCT07454525
Vancouver
Anonymous. Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin. AB Biotics, SA. 2026.
BibTeX
@misc{anon2026Examin,
title = {Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin.},
author = {Anonymous},
journal = {AB Biotics, SA},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.